P09 Long-term obeticholic acid (OCA) for Primary Biliary Cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database
Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A37-A37
10.1136/gutjnl-2022-basl.60